Paul Voss

Paul Voss Email and Phone Number

Principal Consultant (Product Launch - Commercial and Market Access Strategy) @ Osprey BioPharma Strategies, LLC.
United States
Paul Voss's Location
United States, United States
Paul Voss's Contact Details
About Paul Voss

Biopharmaceutical Commercialization, Market Access – Pricing & Reimbursement, Operations & Analytics, Patient Services, and Channel strategy department leader. Extensive start-up, orphan, rare / ultra-rare disease, medical and pharmacy benefit specialty drug launch / competitive launch experience. Proven track record in establishing global commercial and access strategy for multiple therapeutic areas, Payer / PBM – GPO contracting, and public and healthcare policy – advocacy initiatives.Strong negotiator, creative vision, strategic planner, and the ability to motivate and influence with high-energy and relentless passion for patients. Team leader, with solid interpersonal and relationship-building skills, with the ability to quickly assess emergent issues and establish strategies to affect product access and market share opportunity.Biologic & therapeutic background: Ultra-Rare / Rare and Orphan Neurology (Mitochondrial, Amyloidosis, Epilepsy, and Movement Disorders), Neuromuscular, PM&R, Cardiometabolic & Cardiovascular, Interventional Vascular / Oncology / Pulmonology, Ophthalmology / Retinal, Endocrinology / Urology, G.I., Ortho. and Plastic Surgery; Other – Dermatology, Anesthesiology, Pediatric and Neonatology

Paul Voss's Current Company Details
Osprey BioPharma Strategies, LLC.

Osprey Biopharma Strategies, Llc.

View
Principal Consultant (Product Launch - Commercial and Market Access Strategy)
United States
Paul Voss Work Experience Details
  • Osprey Biopharma Strategies, Llc.
    Principal Consultant (Product Launch - Commercial And Market Access Strategy)
    Osprey Biopharma Strategies, Llc.
    United States
  • Rezolute, Inc.
    Vice President, Value, Access & Patient Services
    Rezolute, Inc. Dec 2024 - Present
    Redwood City, California, Us
    View
  • Osprey Biopharma Strategies, Llc.
    Principal Consultant
    Osprey Biopharma Strategies, Llc. Jan 2024 - Present
    Delivering on product commercial and corporate value for emerging and mid-size biopharmaceutical companies.
  • Reneo Pharmaceuticals
    Vice President, Market Access & Policy
    Reneo Pharmaceuticals Jul 2023 - Dec 2023
    Irvine, California, Us
    Corporate-wide Workforce Reduction Resulting From a Negative Phase 2b Pivotal TrialCommercial department leader, responsible for contributing to, and for building a cross-functional, market-ready, Payer, Patient services / experience – reimbursement, and Channel Strategy department. Responsibilities include go-to-market 5-year departmental budget, P&L management, pricing and reimbursement strategy, payer marketing and decisionmaker engagement, channel strategy (3PL, SPP, SD), Patient support and out-of-pocket programs, coding and Provider reimbursement tools, Pricing Compendia, GP, GTN forecasting, state licensure, and competitive PBM access contracting to support labeled product access for a rare, genetically-confirmed, oral PPARδ agonist in Mavodelpar, for Primary Mitochondrial Myopathies (PMM).Deliverables include, the tactical build of market access and reimbursement programs, Qual. / Quant. product / competitive category pricing research, Channel strategy assessment, Patient / HCP services – support benchmarking assessment, and the development of strategic imperatives around quality, value and economic outcomes for Payers / PBMs, HTAs, and organized systems / IDNs. Additional deliverables include pre and post-approval AMCP Dossier, PIE and Value proposition, Traditional Access and Risk-based contract assessment, model policy, and provider / society product access advocacy initiatives.
    View
  • Marinus Pharma
    Vice President, Market Access & Policy
    Marinus Pharma Jan 2022 - Jun 2023
    Radnor, Pa, Us
    Portfolio Commercial leader, responsible for building and leading a cross-functional, market-ready, strategically deployed Payer, Patient services / experience – reimbursement, and Channel Strategy team. Responsibilities include a go-to-market departmental budget, P&L management, pricing and reimbursement strategy, payer marketing and engagement, channel (SPP, SD), Patient support and out-of-pocket programs, coding and Provider reimbursement tools, Pricing Compendia, GP, GTN forecasting, state licensure, and competitive PBM access contracting to support labeled product / portfolio coverage for an ultra-rare pediatric, genetically-confirmed, oral suspension product in ZTALMY® (ganaxolone), for CDKL5 deficiency disordersDeliverables include future state and strategic Commercial pricing and reimbursement, market access, and budget launch strategy for Marinus rare disease Oral and refractory IV Ganaxolone clinical development asset portfolio.
    View
  • Ionis Pharmaceuticals, Inc.
    Executive Director, Market Access & Reimbursement
    Ionis Pharmaceuticals, Inc. Nov 2017 - Jan 2022
    Carlsbad, Ca, Us
    AKCEA THERAPEUTICS - Nov. 2017 - June 2021Portfolio Commercial leader, responsible for building and leading a cross-functional, market-ready, strategically deployed Payer, Patient support – reimbursement, and Channel Strategy team. Responsibilities include a go-to-market departmental budget, P&L management, pricing and reimbursement strategy, payer marketing and engagement, channel (SPP, SD), Patient support and out-of-pocket programs, coding and Provider reimbursement tools, Pricing Compendia, GP, GTN forecasting, state licensure, and competitive PBM access contracting to support labeled product / portfolio coverage for two ultra-rare, genetically-confirmed, antisense RNA-targeted products in TEGSEDI® (inotersen), for Hereditary Transthyretin (TTR) Amyloidosis, and WAYLIVRA® (volanesorsen), for familial chylomicronemia syndrome.* Deliverables also included Commercial pricing and reimbursement, and market access launch strategy for the Ionis Pharmaceuticals “owned” and “out-licensed” clinical development asset portfolio.
    View
  • Btg Plc
    Senior Director, Global Market Access
    Btg Plc Feb 2013 - Aug 2017
    Marlborough, Massachusetts, Us
    SENIOR DIRECTOR, GLOBAL MARKET ACCESS June 2016Portfolio team leader, responsible for building and leading a strategically deployed US payer (Commercial & Public), provider / systems reimbursement, Global / Ex-US access, and GPO field facing teams. Responsibilities include the development and implementation of a VARITHENA® (polidocanol injectable foam) market access payer engagement and product reimbursement launch strategy, Physician HUB and Patient services, Specialty Pharmacy and Distribution channel partnerships to support labeled product portfolio access / country funding, coding and payment.Global product business partner, responsible for identifying future state market access strategies and tactics that drive revenue and support Commercial strategic imperatives around quality, value and economic outcomes for organized systems, payers, and countries. Deliverables include advocacy, model medical policy, BIM, Graphical User Interface tools, risk-based and GPO contract strategies. BTG’s product portfolio included Interventional Endovascular drug / devices, implantable Oncology Beads, Radiopharmaceutical, and Acute Care antidotes. NATIONAL ACCOUNT DIRECTOR, WEST Global Market Access team member responsible for managing western US national Commercial (UHC, OptumRx, Anthem, Kaiser, HealthNet, Prime) and Public payer (MACs JE, JF, J5, J6) accounts, and leading a strategically deployed team of Regional Account Managers and Field-based Provider / Hospital Reimbursement Managers.• Supported the build of the BTG Market Access team (50+ members globally)• HUB service provider identification (including RFP build, selection and deployment)• “Limited” SPP network buildout (including RFP, contract template creation, partner selection and deployment)
    View
  • Merz Therapeutics
    National Account Manager
    Merz Therapeutics Dec 2011 - Jul 2012
    Frankfurt Am Main, De
    Identification, development, and advancement of market access and reimbursement strategy for XEOMIN® (incobotulinumtoxinA). This included the management of a strategically deployed account team (including VA/DoD-Tricare), HUB services, and western national / regional Commercial and public payer accounts, and specialty pharmacy relationships.Maintenance and enhancement of Commercial and Government healthcare policy, pharmacoeconomic value proposition, and execution of long-term and ad-hoc payer, PMB, and individual Provider and alliance advocacy supported initiatives.
    View
  • Alimera Sciences
    Director, Payer Relations
    Alimera Sciences Sep 2011 - Dec 2011
    Alpharetta, Georgia, Us
    FDA CRL, Corporate Wide DownsizingStrategic Commercial launch support for ILUVIEN® (fluocinolone acentonide intravitreal implant). Payer segmentation and the creation Commercial and Government model healthcare policy, provider reimbursement tools, Patient HUB and Specialty Pharmacy services rollout.Prepared to manage Commercial and Government Payer and PBM national / regional accounts in the West Coast and Mountain states, and the development of HCP / sales force identified reimbursement resources and tools.
    View
  • Auxilium Pharmaceuticals
    National Account Director
    Auxilium Pharmaceuticals May 2009 - Sep 2011
    Us
    Managed large national and regional Commercial, PBM and public accounts in the Pacific Northwest, Mountain states and MidwestStrategic orphan rare-disease Commercial launch support of XIAFLEX® (collagenase clostridial histolyticum) for outpatient physician injection, with the objective of reducing physician / patient barriers to access, including TESTIM®1% (testosterone gel). Established and maintained Commercial and Gov. healthcare policy, pharmacy benefit product contract negotiations, and development of field sales pull-through tools.
    View
  • Prolacta Bioscience
    Director, Reimbursement Western Us
    Prolacta Bioscience Sep 2008 - May 2009
    City Of Industry, Ca, Us
    Managed western US Commercial and Medicaid Government accounts. Implemented reimbursement strategies for Payers, Hospitals and Providers. Created and maintained healthcare policy and developed Government and Commercial, individual and alliance-type advocate base for long-term and ad-hoc situations. Analyzed overall state and national healthcare environment to support legislative / lobbying activity.
    View
  • Allergan
    Regional Healthcare Policy Manager
    Allergan Apr 2002 - Sep 2008
    Dublin, Coolock, Ie
    •REGIONAL HEALTHCARE POLICY MANAGER (BOTOX® & LAPBAND®): Feb. 2007-Sept. 2008•Managing Medicare and Medicaid public payer accounts. Responsible for the creation and protection of healthcare policy, and Medicaid contracting for ophthalmology, urology, and dermatology. •SENIOR (Provider Facing) REIMBURSEMENT BUSINESS MANAGER: April 2004 - Jan. 2007•BOTOX MEDICAL CONSULTANT: April 2002 - April 2004
    View
  • Mylan - Bertek Pharmaceuticals
    Territory Sales Manager (Neuroscience)
    Mylan - Bertek Pharmaceuticals Apr 1998 - Apr 2002
    Canonsburg, Pennsylvania, Us
    •TERRITORY SALES MANAGER (NeuroCare Specialty Division) 2001 - 2002•REGIONAL ACCOUNT MANAGER (Supporting West Region NAM) 2000 - 2002•CORPORATE NEW HIRE TRAINER 1999 - 2002•PRIMARY CARE AND SPECIALTY SALES 1998 - 2001
    View

Paul Voss Skills

Product Launch Buy And Bill Managed Markets Pharmaceutical Industry Cross Functional Team Leadership Medicare Healthcare Biotechnology Account Management Neurology Managed Care Strategic Planning National Accounts Pharmaceutical Sales Health Policy Market Access Selling Specialty Pharmaceutical Dermatology Urology Medicare/medicaid Reimbursement Business Acumen Strategy Healthcare Policy Reimbursement Contract Negotiation Market Planning Leadership Endocrinology Start Ups Healthcare Coding Internal Medicine Hub Implementation Commercial Payers Sales Public Payers Medical Coding Influence Without Authority Leadership Development Coaching Specialty Pharma Oncology Interventional Radiology Orthopedics Orthopedic Interventional Cardiology Vascular Surgery Payments Neuroscience

Paul Voss Education Details

  • Oregon State University
    Oregon State University
    Bachelor Of Science

Frequently Asked Questions about Paul Voss

What company does Paul Voss work for?

Paul Voss works for Osprey Biopharma Strategies, Llc.

What is Paul Voss's role at the current company?

Paul Voss's current role is Principal Consultant (Product Launch - Commercial and Market Access Strategy).

What is Paul Voss's email address?

Paul Voss's email address is pv****@****rma.com

What is Paul Voss's direct phone number?

Paul Voss's direct phone number is +161027*****

What schools did Paul Voss attend?

Paul Voss attended Oregon State University.

What skills is Paul Voss known for?

Paul Voss has skills like Product Launch, Buy And Bill, Managed Markets, Pharmaceutical Industry, Cross Functional Team Leadership, Medicare, Healthcare, Biotechnology, Account Management, Neurology, Managed Care, Strategic Planning.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.